Fecal Microbiota Transplantation & Cholangitis
Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical Trial.
Fecal Microbiota Transplantation for Primary Sclerosing Cholangitis-A Beautiful but Incomplete Story.
Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: The Next Steps in This Promising Story.
Liver-Microbiome Axis in Health and Disease.
Healthy Donor Fecal Microbiota Transplantation for Recurrent Bacterial Cholangitis in Primary Sclerosing Cholangitis - A Single Case Report.
New Therapeutic Targets in Autoimmune Cholangiopathies.
Intestinal microbiota in primary sclerosing cholangitis.
Gut microbiome in primary sclerosing cholangitis: A review.
Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?
Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease.
Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional Framework.
The Microbiome and Primary Sclerosing Cholangitis.
Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic gammadelta T-Cell Receptor-Positive Cells and Pathogenesis of Cholestatic Liver Disease.
New Therapeutic Strategies for Primary Sclerosing Cholangitis.
Manipulation of the Gut-Liver Axis Using Microbiome Restoration Therapy in Primary Sclerosing Cholangitis.
Emerging pharmacologic therapies for primary sclerosing cholangitis.
Emerging treatments for primary sclerosing cholangitis.